NCT05572866View on ClinicalTrials.gov

Impact of COVID-19 Pandemic on Hepatopancreatobiliary Surgical Services in Singapore

CompletedOBSERVATIONAL
Enrollment

1,089

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
COVID-19Surgery
Interventions
OTHER

COVID-19 pandemic

To retrospectively review the surgical volume across 2019-2022 to see the impact of the COVID-19 pandemic.

Trial Locations (1)

308433

Tan Tock Seng Hospital, Singapore

All Listed Sponsors
lead

Tan Tock Seng Hospital

OTHER

NCT05572866 - Impact of COVID-19 Pandemic on Hepatopancreatobiliary Surgical Services in Singapore | Biotech Hunter | Biotech Hunter